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female sexual functionDear Editor,
Sakinci et al [1] stated that “women who were found to be
eligible for the study were instructed to ﬁll the Female Sexual Func-
tion Index (FSFI)… FSFI is regarded as a gold standard measure of
female sexual functioning ”.
Questionnaires are used to establish the diagnosis and to assess
the response to treatment of female sexual dysfunction (FSD). Prev-
alence data suggest that 10e42% of women experience orgasmic
disorder. If a woman has an orgasm through clitoral stimulation
but not during intercourse, it does notmeet the criteria for a clinical
diagnosis of female orgasmic disorder. If the orgasmic difﬁculties
are the result of an inadequate sexual stimulation, these cases
should not be diagnosed as a disorder of female orgasm [2].
The FSFI questionnaire is the most widely used measures of FSD
cited in more than 1500 articles. However, the validity of the FSFI
has not been addressed in the literature [3]. Physiologically, the
FSFI does not provide an assessment of female sexual function; it
contains mainly psychological items, as may be seen in FSFI Items
1 and 2 (domain desire), 6 (domain arousal: satisfaction), 13
(domain orgasm: satisfaction), and 14e16 (domain satisfaction).
Items 17e19 (domain pain) measure pain level during or following
vaginal penetration. In the questions on arousal, lubrication,
orgasm, and pain, the words “satisfaction” and “intercourse” are
used. The FSFI seems to assess the degree of lubrication and ease
of penetration, whereas very little attention is paid to clitoral sensa-
tion. In fact, a decline in desire and a decreased ability to achieve
orgasm are associated speciﬁcally with penileevaginal intercourse.
As a matter of fact, FSD as a concept is popular because it is
based on something that does not exist, i.e., the vaginal orgasm.
Female orgasm is caused by the female erectile organs (i.e., clitoris,
vestibular bulbs, labia minora, and corpus spongiosum of the fe-
male urethra), and physiologically female sexual satisfaction is
based on orgasm and resolution. In all women, orgasm is always
possible if the female erectile organs are effectively stimulated
during masturbation, cunnilingus, and partner masturbation, or
during vaginal intercourse if the clitoris is simply stimulated
with a ﬁnger [4].
The FSFI questionnaire must not be used to assess female sexual
function. Questionnaires for the diagnosis and treatment of FSD
must mainly assess the presence or absence of orgasm withhttp://dx.doi.org/10.1016/j.tjog.2016.04.031
1028-4559/Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published b
(http://creativecommons.org/licenses/by-nc-nd/4.0/).masturbation, and in the questions the words “intercourse” or
“satisfaction” must not be used.
Moynihan [5], in 2010, stated: “I described the making of FSD as
the freshest, clearest example of the corporate sponsored creation
of a disease... The item female sexual function index, published in
2000, was supported by Bayer and Zonagen at a time they hoped
to treat so called arousal disorder. The sexual function question-
naire was funded by Pﬁzer, and half of the authors on the 2002 pa-
per describing its development were Pﬁzer employees, including
the lead author”.
FSD has become the centre of a multimillion dollar business: Is
FSD an illness constructed by sexual medicine experts under the in-
ﬂuence of drug companies?
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